Home » Topics » BioWorld Science

BioWorld Science
RSS

NEK7 identified as potential biomarker associated with obsessive compulsive disorder

Sep. 12, 2019

S100-B found to be a peripheral biomarker for estimating addiction treatment efficacy

Sep. 12, 2019

ANKRD12 as a novel biomarker in schizophrenia and bipolar disorder

Sep. 12, 2019

Positive CTC data from phase II TYME-88-PANC study of SM-88

Sep. 12, 2019

Tiziana presents phase I results for nasal foralumab

Sep. 12, 2019

Molecular Partners initiates first-in-human study of MP-0310

Sep. 12, 2019

Murine model reveals TRPA1 loss is involved in age-related dilated cardiomyopathy

Sep. 12, 2019

Pfizer reports preliminary data from phase II pediatric study of 20vPnC candidate

Sep. 10, 2019

Translate Bio discontinues MRT-5201 for OTC deficiency, prioritizes pulmonary disease programs

Sep. 10, 2019

Alector begins phase II study of AL-001 for frontotemporal dementia

Sep. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...